FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Alane Koki

Research Profile

Chemicals & Drugs

Procedures

Immunohistochemistry

Living Beings

Mouse
Rats

Physiology

Phenomena

Blotting, Western

Disorders

Co-author Network

Publications

TOP 3
Jocelyne Jacquemier; christophe ginestier; Jacques Rougemont; Valérie-Jeanne Bardou; Emmanuelle Charafe-Jauffret; Jeannine Geneix; José Adélaïde; Alane T Koki; Gilles Houvenaeghel; Jacques Hassoun; Dominique Maraninchi; Patrice Viens; Daniel Birnbaum; François Bertucci
Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.
Dave Cervi; Giannoula Klement; Diana Stempak; Sylvain Baruchel; Alane T Koki; Yaacov Ben David
Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend disease.
Kai Wang; Khaldoun Tarakji; Zhongmin Zhou; Ming Zhang; Farhad Forudi; Xiaorong Zhou; Alane T Koki; Mark E Smith; Bradley T Keller; Eric J Topol; A Michael Lincoff; Marc S Penn
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Alane Koki (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2005: Jocelyne Jacquemier; christophe ginestier; Jacques Rougemont; Valérie-Jeanne Bardou; Emmanuelle Charafe-Jauffret; Jeannine Geneix; José Adélaïde; Alane T Koki; Gilles Houvenaeghel; Jacques Hassoun; Dominique Maraninchi; Patrice Viens; Daniel Birnbaum; François Bertucci
Protein expression profiling identifies subclasses of breast cancer and predicts prognosis.
Cancer research 2005;65(3):767-79.
2005: Dave Cervi; Giannoula Klement; Diana Stempak; Sylvain Baruchel; Alane T Koki; Yaacov Ben David
Targeting cyclooxygenase-2 reduces overt toxicity toward low-dose vinblastine and extends survival of juvenile mice with Friend disease.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(2 Pt 1):712-9.
2005: Kai Wang; Khaldoun Tarakji; Zhongmin Zhou; Ming Zhang; Farhad Forudi; Xiaorong Zhou; Alane T Koki; Mark E Smith; Bradley T Keller; Eric J Topol; A Michael Lincoff; Marc S Penn
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
Journal of cardiovascular pharmacology 2005;45(1):61-7.
2004: N Maroc; A Morel; Emmanuel Beillard; A L De La Chapelle; Xavier Fund; Marie-Joëlle Mozziconacci; M Dupont; Jean-Michel Cayuela; Jean Gabert; Alane T Koki; Vincent Fert; fabienne hermitte
A diagnostic biochip for the comprehensive analysis of MLL translocations in acute leukemia.
Leukemia 2004;18(9):1522-30.
2004: François Bertucci; Nathalie Borie; christophe ginestier; Agnès Groulet; Emmanuelle Charafe-Jauffret; José Adélaïde; Jeannine Geneix; Loïc Bachelart; Pascal Finetti; Alane T Koki; fabienne hermitte; Jacques Hassoun; Stéphane Debono; Patrice Viens; Vincent Fert; Jocelyne Jacquemier; Daniel Birnbaum
Identification and validation of an ERBB2 gene expression signature in breast cancers.
Oncogene 2004;23(14):2564-75.
2004: Dave Cervi; Amandine H L Truong; Jane S Lee; Natasha Sukhai; You-Jun Li; Alane T Koki; Yaacov Ben David
Phosphorylation status of c-Kit and Epo receptors, and the presence of wild-type p53 confer in vitro resistance of murine erythroleukemic cells to Celecoxib.
Oncogene 2004;23(13):2305-14.
2003: Anne-Christine Goulet; Janine G Einsphar; David S Alberts; Anthony Beas; Cynthia Burk; Achyut Bhattacharyya; Jerry Bangert; Janet M Harmon; Hideji Fujiwara; Alane T Koki; Mark A Nelson
Analysis of cyclooxygenase 2 (COX-2) expression during malignant melanoma progression.
Cancer biology & therapy 2003;2(6):713-8.
2003: Traci A Wilgus; Alane T Koki; Ben S Zweifel; Donna F Kusewitt; Patricia A Rubal; Tatiana M Oberyszyn
Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment.
Molecular carcinogenesis 2003;38(2):49-58.
2003: Traci A Wilgus; Alane T Koki; Ben S Zweifel; Patricia A Rubal; Tatiana M Oberyszyn
Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer.
Molecular carcinogenesis 2003;38(1):33-9.
2003: Marta López-Parra; Joan Clària; Anna Planagumà; Esther Titos; Jaime L Masferrer; B Mark Woerner; Alane T Koki; Wladimiro Jiménez; Vicente Arroyo; Francisca Rivera; Juan Rodés
Renal effects of selective cyclooxygenase inhibition in experimental liver disease.
Advances in experimental medicine and biology 2003;525():133-6.
2002: Medora M Hardy; Karen Seibert; Pamela T Manning; Mark G Currie; B Mark Woerner; Dorothy Edwards; Alane T Koki; Catherine S Tripp
Cyclooxygenase 2-dependent prostaglandin E2 modulates cartilage proteoglycan degradation in human osteoarthritis explants.
Arthritis and rheumatism 2002;46(7):1789-803.
2002: Alane T Koki; Jaime L Masferrer
Celecoxib: a specific COX-2 inhibitor with anticancer properties.
Cancer control : journal of the Moffitt Cancer Center 2002;9(2 Suppl):28-35.
2002: Marta López-Parra; Joan Clària; Anna Planagumà; Esther Titos; Jaime L Masferrer; B Mark Woerner; Alane T Koki; Wladimiro Jiménez; Rosario Altuna; Vicente Arroyo; Francisca Rivera; Juan Rodés
Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
British journal of pharmacology 2002;135(4):891-900.
2002: Kathleen M Leahy; Richard L Ornberg; Yu Wang; Ben S Zweifel; Alane T Koki; Jaime L Masferrer
Cyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivo.
Cancer research 2002;62(3):625-31.
2002: Alane T Koki; Nasir K Khan; B Mark Woerner; Andrew J Dannenberg; Lisa Olson; Karen Seibert; Dorothy Edwards; Madorra Hardy; Peter C Isakson; Jaime L Masferrer
Cyclooxygenase-2 in human pathological disease.
Advances in experimental medicine and biology 2002;507():177-84.
2002: Alane T Koki; Nasir K Khan; B Mark Woerner; Karen Seibert; J L Harmon; A J Dannenberg; Robert A Soslow; Jaime L Masferrer
Characterization of cyclooxygenase-2 (COX-2) during tumorigenesis in human epithelial cancers: evidence for potential clinical utility of COX-2 inhibitors in epithelial cancers.
Prostaglandins, leukotrienes, and essential fatty acids 2002;66(1):13-8.
2001: Hussein Abou-Issa; Galal A Alshafie; Karen Seibert; Alane T Koki; J L Masferrer; Randall E Harris
Dose-response effects of the COX-2 inhibitor, celecoxib, on the chemoprevention of mammary carcinogenesis.
Anticancer research 2001;21(5):3425-32.
2001: Tariq Khan; Jaime L Masferrer; B Mark Woerner; Robert A Soslow; Alane T Koki
Enhanced cyclooxygenase-2 expression in sporadic and familial adenomatous polyposis of the human colon.
Scandinavian journal of gastroenterology 2001;36(8):865-9.
2001: S Kulkarni; Janet S Rader; F Zhang; H Liapis; Alane T Koki; Jaime L Masferrer; Kotha Subbaramaiah; Andrew J Dannenberg
Cyclooxygenase-2 is overexpressed in human cervical cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(2):429-34.
2000: Robert A Soslow; Andrew J Dannenberg; D Rush; B Mark Woerner; Tariq Khan; Jaime L Masferrer; Alane T Koki
COX-2 is expressed in human pulmonary, colonic, and mammary tumors.
Cancer 2000;89(12):2637-45.
2000: Kathleen M Leahy; Alane T Koki; Jaime L Masferrer
Role of cyclooxygenases in angiogenesis.
Current medicinal chemistry 2000;7(11):1163-70.
2000: Clinton J Grubbs; Ronald A Lubet; Alane T Koki; Kathleen M Leahy; Jaime L Masferrer; Vernon E Steele; Gary J Kelloff; Donald L Hill; Karen Seibert
Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats.
Cancer research 2000;60(20):5599-602.
2000: Jaime L Masferrer; Kathleen M Leahy; Alane T Koki; Ben S Zweifel; S L Settle; B Mark Woerner; DA Edwards; A G Flickinger; R J Moore; Karen Seibert
Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors.
Cancer research 2000;60(5):1306-11.
2000: Yoel Sadovsky; D Michael Nelson; Louis J Muglia; Gilad A Gross; K C Harris; Alane T Koki; J L Masferrer; L M Olson
Effective diminution of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2.
American journal of obstetrics and gynecology 2000;182(2):370-6.
1999: Sulma I Mohammed; Deborah W Knapp; D G Bostwick; R S Foster; Tariq Khan; Jaime L Masferrer; B Mark Woerner; Paul W Snyder; Alane T Koki
Expression of cyclooxygenase-2 (COX-2) in human invasive transitional cell carcinoma (TCC) of the urinary bladder.
Cancer research 1999;59(22):5647-50.
1999: G Chan; Jay O Boyle; Eun K Yang; F Zhang; Peter G Sacks; Jatin P Shah; Diane Edelstein; Robert A Soslow; Alane T Koki; B Mark Woerner; Jaime L Masferrer; Andrew J Dannenberg
Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck.
Cancer research 1999;59(5):991-4.
1999: Olga N Tucker; Andrew J Dannenberg; Eun K Yang; F Zhang; Lisong Teng; John M Daly; Robert A Soslow; Jaime L Masferrer; B Mark Woerner; Alane T Koki; Thomas J Fahey
Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer.
Cancer research 1999;59(5):987-90.
1999: Jaime L Masferrer; Alane T Koki; Karen Seibert
COX-2 inhibitors. A new class of antiangiogenic agents.
Annals of the New York Academy of Sciences 1999;889():84-6.
1999: Richard L Ornberg; Alane T Koki
Visualization and quantitation of cyclooxygenase-1 and -2 activity by digital fluorescence microscopy.
Advances in experimental medicine and biology 1999;469():131-7.
1999: SY Buckman; Alane T Koki; DA Edwards; AP Pentland
Immunohistochemical analysis of cyclooxygenase expression in human skin.
Methods in molecular biology (Clifton, N.J.) 1999;120():35-43.
1998: Tariq Khan; C M Venturini; Roderick T Bunch; J A Brassard; Alane T Koki; Dale L Morris; BF Trump; Timothy J Maziasz; Carl L Alden
Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.
Toxicologic pathology 1998;26(5):612-20.